Applied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboratio

- Agreement Leverages Company’s Ability for Intramuscular Delivery of LNP-Encapsulated LinearDNA-based Therapies for Veterinary Therapeutic and Prophylactic Applications -STONY BROOK, N.Y. & ITHICA, N.Y.--(BUSINESS WIRE)--$APDN #CUCVM--Applied DNA Sciences, Inc. (NASDAQ: APDN) (‘Applied DNA’ or the “Company”), a lea...

Related Keywords

Jamesa Hayward ,United State Department Of Agriculture ,Linkedin ,Sciences Inc ,Twitter ,Drug Administration ,Cornell University College Of Veterinary Medicine ,Nasdaq ,Agreement Leverages Company Ability For Intramuscular Delivery ,Securities Exchange ,Company For The ,Leverages Company ,Intramuscular Delivery ,Veterinary Therapeutic ,Prophylactic Applications ,Cornell University College ,Veterinary Medicine ,Diego Diel ,Associate Professor ,Population Medicine ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,United State Department ,Annual Report ,Quarterly Report ,Brian Viscount ,